Lake Bleu Capital

Lake Bleu Capital is a Hong Kong-based private equity firm specializing in healthcare investments across Asia, particularly Greater China. The firm focuses on mid- to late-stage companies in sectors such as pharmaceuticals, biotech, medical devices, and healthcare services. With a long-term investment horizon, Lake Bleu Capital manages strategies across the entire healthcare value chain, aiming to build enduring leaders in the industry.

The firm's investment approach includes both public and private equity, targeting companies with significant growth potential. Lake Bleu Capital's limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices from around the world. The firm operates in Hong Kong and Shanghai, leveraging its extensive network to support portfolio companies in achieving sustainable progress.

Lake Bleu Capital's portfolio includes notable companies such as RecBio, AffaMed Therapeutics, and BANGBANG ROBOT. The firm's leadership includes Founding Partner and CEO Bin Li, who studied at Fudan University. Lake Bleu Capital's commitment to healthcare investment is underscored by its active participation in the sector, with a focus on creating value through strategic partnerships and operational expertise.